TSPO and lip and oral cavity carcinoma: These observations indirectly suggest that PK 11195 ligand expression decreased by TSPO may lead to the development of malignant lesions, including oral cancers, due to inhibition of apoptosis and, consequently, uncontrolled division of damaged cells.